Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

a white solid with madicaion

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Letrozole Manufacturers in India Suppliers Letrozole Exporters Distributors Letrozole api active pharmaceuticals ingredients Letrozole manufacturers Side Effects bulk drugs raw material Letrozole companies Side Effects Importers Letrozole Letrozole Exporters Letrozole exporters FDA Letrozole DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Letrozole manufacturing pharmaceutical drugs pharmaceutical intermediates Letrozole pharmaceutical chemicals pharmaceutical raw materials Letrozole active pharmaceutical ingredients Letrozole committee active pharmaceutical ingredients manufacturer Letrozole Active Pharmaceutical Ingredients manufacturer Letrozole exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Letrozole, Letrozole manufacturer India, Letrozole product, Letrozole products, Api preparation, Certificate of Analysis API manufacturer product, Letrozole anti ulcer product, Certificate of Origin COA Letrozole COS Letrozole, pharmaceutical generic, pharmaceutical drug, medical, Letrozole pharma healthcare, pharma patents, contract MSDS manufacturing Trader Letrozole pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Letrozole expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Letrozole DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Letrozole ingredients, api, HIV Letrozole, tablets, capsules, syrup & protein Letrozole powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Letrozole gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Letrozole WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

taj pharma Letrozole











 









 

 

 

HOME >> API >> API List 2 >> Letrozole >> Precautions

Letrozole  Molecular Formula C17H11N5

PRECAUTIONS
Letrozole CAS Registry Number 112809-51-5

Nursing Mothers

It is not known if letrozole is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when letrozole is administered to a nursing woman (see WARNINGS and PRECAUTIONS).
Pediatric Use

The safety and effectiveness in pediatric patients have not been established.
Geriatric Use

The median age of patients in all studies of first-line and second-line treatment of metastatic breast cancer was 64-65 years. About 1/3 of the patients were ≥ 70 years old. In the first-line study, patients ≥ 70 years of age experienced longer time to tumor progression and higher response rates than patients < 70.

For the extended adjuvant setting, more than 5,100 postmenopausal women were enrolled in the clinical study. In total, 41% of patients were aged 65 years or older at enrollment, while 12% were 75 or older. In the extended adjuvant setting, no overall differences in safety or efficacy were observed between these older patients and younger patients, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

In the adjuvant setting, more than 8,000 postmenopausal women were enrolled in the clinical study. In total, 36 % of patients were aged 65 years or older at enrollment, while 12% were 75 or older. More adverse events were generally reported in elderly patients irrespective of study treatment allocation. However, in comparison to tamoxifen, no overall differences with regards to the safety and efficacy profiles were observed between elderly patients and younger patients.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS >>
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Letrozole

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.